2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
详细信息 查看全文
- 作者：A. J. Demetris ; C. Bellamy ; S. G. Hü ; bscher ; J. O'Leary ; P. S. Randhawa ; S. Feng ; D. Neil ; R. B. Colvin ; G. McCaughan ; J. J. Fung ; A. Del Bello ; F. P. Reinholt ; H. Haga ; O. Adeyi ; A. J. Czaja ; T. Schiano ; M. I. Fiel ; M. L. Smith ; M. Sebagh ; R. Y. Tanigawa ; F. Yilmaz ; G. Alexander ; L. Baiocchi ; M. Balasubramanian ; I. Batal ; A. K. Bhan ; J. Bucuvalas ; C. T. S. Cerski ; F. Charlotte ; M. E. de Vera ; M. ElMonayeri ; P. Fontes ; E. E. Furth ; A. S. H. Gouw ; S. Hafezi-Bakhtiari ; J. Hart ; E. Honsova ; W. Ismail ; T. Itoh ; N. C. Jhala ; U. Khettry ; G. B. Klintmalm ; S. Knechtle ; T. Koshiba ; T. Kozlowski ; C. R. Lassman ; J. Lerut ; J. Levitsky ; L. Licini ; R. Liotta ; G. Mazariegos ; M. I. Minervini ; J. Misdraji ; T. Mohanakumar ; J. Mö ; lne ; I. Nasser ; J. Neuberger ; M. O'Neil ; O. Pappo ; L. Petrovic ; P. Ruiz ; Ö ; . Sağol ; A. Sanchez Fueyo ; E. Sasatomi ; A. Shaked ; M. Shiller ; T. Shimizu ; B. Sis ; A. Sonzogni ; H. L. Stevenson ; S. N. Thung ; G. Tisone ; A. C. Tsamandas ; A. Wernerson ; T. Wu ; A. Zeevi and Y. Zen
- 刊名：American Journal of Transplantation
- 出版年：2016
- 出版时间：October 2016
- 年：2016
- 卷：16
- 期：10
- 页码：2816-2835
- 全文大小：1233K
- ISSN：1600-6143
文摘
The Banff Working Group on Liver Allograft Pathology reviewed and discussed literature evidence regarding antibody-mediated liver allograft rejection at the 11th (Paris, France, June 5–10, 2011), 12th (Comandatuba, Brazil, August 19–23, 2013), and 13th (Vancouver, British Columbia, Canada, October 5–10, 2015) meetings of the Banff Conference on Allograft Pathology. Discussion continued online. The primary goal was to introduce guidelines and consensus criteria for the diagnosis of liver allograft antibody-mediated rejection and provide a comprehensive update of all Banff Schema recommendations. Included are new recommendations for complement component 4d tissue staining and interpretation, staging liver allograft fibrosis, and findings related to immunosuppression minimization. In an effort to create a single reference document, previous unchanged criteria are also included.